Co-Diagnostics Withdraws FDA Application for Covid Test
The decision to withdraw is based on discussions Co-Diagnostics had with the FDA about the ability to detect a potential deterioration of one component of the test, related to shelf-life stability, it ...
Co-Diagnostics withdraws 510k application to FDA for Co-Dx PCR COVID-19 Test
Co-Diagnostics (CODX) announced that, following a collaborative and informative dialogue with the Food and Drug Administration, the company has ...
The Herald Journal1d
Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance
The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component ...
Nature3d
AI tool diagnoses diabetes, HIV and COVID from a blood sample
One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...